← Back to all trials
Recruiting
NCT07713940
Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
Conditions: Systemic Lupus Erthematosus (SLE)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 36
Sponsor: University of California, San Diego
Location: Altman Clinical Translational Research Insitute (UC San Diego) La Jolla California
Summary
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
Eligibility Criteria
Inclusion Criteria:
* patients who meet the 2019 EULAR/ACR Classification Criteria for SLE
* patients who are on Cellcept or Myfortic for at least 3 months prior to screening
* patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale.
Exclusion Criteria:
* pregnant or lactating patients,
* patients with food allergy
* patients on antibiotics within 4 weeks of the screening
* patients that change the SLE therapy during the length of the study (12 weeks).
Source: ClinicalTrials.gov (NCT07713940). StuddyBuddy aggregates publicly available trial information.
